ArticleBMC geriatrics2026
Association of multimorbidity and its patterns with risk of mortality among the elderly in Shenzhen, China.
Article in BMC geriatrics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
objectiveThis study aimed to identify multimorbidity pattern in the elderly population, and to investigate the associations of multimorbidity and its patterns with risk of mortality.
methodsA total of 107,217 participants aged ≥ 65, with 47,205 men and 60,012 women, were enrolled from Shenzhen, China in 2018 and followed up to 2023. Hierarchical cluster analysis was used to identified multimorbidity pattern among 10 chronic diseases. Cox proportional hazard model was used to measure mortality risk of multimorbidity and its patterns.
resultsMultimorbidity was present in 74,545 participants (69.53%). Three multimorbidity patterns were identified: cardiometabolic pattern (including 47,020 participants, comprising cardiovascular disease, cerebrovascular disease, hypertension, dyslipidemia, and diabetes); sensory and hepatic disorder pattern (including 11,766 participants, comprising liver disease, hearing impairment, and visual impairment); and hematological-renal pattern (including 1,961 participants, comprising kidney disease and anemia). Compared with participants without multimorbidity, the hazard ratios (HRs) for mortality were 1.29 (95% CI: 1.22–1.37, P < 0.001) for multimorbidity, 1.36 (95% CI: 1.28–1.44, P < 0.001) for cardiometabolic pattern, 1.20 (95% CI: 1.10–1.30, P < 0.001) for sensory and hepatic disorder pattern and 1.94 (95% CI: 1.66–2.31, P < 0.001) for hematological-renal pattern.
conclusionsIn this prospective study of 107,217 participants aged ≥ 65 years, we demonstrated that multimorbidity was associated with an increased mortality risk. Three distinct multimorbidity patterns were identified, each of which conveyed a heightened mortality risk warranting further attention. These findings offer a scientific reference for future research and clinical management of multimorbidity in older adults.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.